Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san diego blog main
san diego top stories
8
×
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
clinical trials
san francisco blog main
san francisco top stories
pfizer
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
drugs
national
akcea therapeutics
celgene
genentech
immunotherapy
inotersen
intercept pharmaceuticals
merck
What
approved
8
×
drug
fda
bio
disease
medicine
alnylam
cancer
companies
fatty
genetic
known
liver
merck
nash
new
news
oks
pfizer
roundup
time
adu
afternoon
agency
ago
aimmune
akcea
allergy
alnylam’s
amyloidosis
approval
attr
available
awarded
battle
beats
bids
biogen
combo
complicated
Language
unset
Current search:
approved
×
" san diego top stories "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug